| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |